Does Insurance Cover Spravato in Texas?

Does insurance cover SPRAVATO® (esketamine) in Texas? Many plans, including commercial plans, Texas Medicaid and Medicare, have a path to paying for it. That path almost always runs through prior authorization: a review in which your plan checks your records against its own criteria before it agrees to pay. The criteria, and what you owe, depend on your type of coverage. This guide walks through each one, explains where the manufacturer's savings programs fit, and ends with a list of what to gather before a benefits check.

Why does Spravato need prior authorization if it's FDA-approved?

FDA approval means a medicine can be prescribed for specific uses. It doesn't decide who pays. Each plan sets its own rules for when Spravato is medically necessary, and prior authorization (PA) is how it applies them.

Spravato's FDA label covers adults with treatment-resistant depression (TRD), on its own or with an oral antidepressant, and depressive symptoms in adults with major depressive disorder (MDD) who have acute suicidal thoughts or behavior, used with an oral antidepressant. Thinking about suicide? Call or text 988. Plan criteria usually center on the first: documented treatment-resistant depression. In practice, that means records showing your depression hasn't improved enough after at least two antidepressants taken at an adequate dose for long enough. Some plans ask for more. Our guide to who may qualify for Spravato explains the term.

The setting matters too. Spravato is given only at healthcare settings certified in the SPRAVATO REMS, an FDA-required safety program. You take the nasal spray yourself while a healthcare provider supervises, and you're monitored for at least 2 hours afterward. So a Spravato visit has two parts that can be billed separately: the medicine and the observation time.

Does insurance cover Spravato on commercial plans?

Criteria vary and change over time, but the paperwork looks similar. The manufacturer's prior authorization toolkit for clinics lists what plans typically request:

• Proof that at least two oral antidepressants didn't work well enough, including the dose, how long you took each one and pharmacy fill dates.
• A baseline depression score from a standard rating scale, such as the PHQ-9.
• Confirmation that both the treatment site and the pharmacy are certified in the SPRAVATO REMS.
• Sometimes more: a check that bipolar disorder has been ruled out, a history of psychotherapy, or a blood pressure and heart assessment.

Here is one dated example. UnitedHealthcare's commercial and individual exchange policy (No. 2026D0069Q, effective May 1, 2026) asks for a diagnosis of treatment-resistant MDD and failure of at least two different antidepressants, each taken at an adequate dose for at least 8 weeks. It also asks for a baseline rating-scale score, and the plan's own criteria call for a psychiatrist to prescribe Spravato or be involved in the patient's care. The policy allows Spravato for TRD alone or with an oral antidepressant. An initial approval lasts up to 12 months; renewal requires a recent score showing improvement from your baseline. Your plan may differ, and policies change.

The "alone or with an antidepressant" detail is worth asking about. The FDA approved Spravato on its own for TRD in January 2025, and plans have updated their criteria at different speeds. Some may still expect an oral antidepressant alongside it.

Does Texas Medicaid cover Spravato?

Texas Medicaid has a prior authorization process for Spravato for adults 18 and older with major depressive disorder. Its published criteria allow Spravato on its own (monotherapy) for adults with treatment-resistant depression, and they also call for direct observation with at least 2 hours of monitoring and a baseline depression rating-scale score.

Two caveats:

• Managed care plans can differ. If you're in a Medicaid managed care plan, such as STAR or STAR+PLUS, that plan runs its own process. Texas Medicaid's claims administrator notes that managed care procedures "may differ from traditional Medicaid (fee-for-service) and from MCO to MCO."
• The number of failed medications isn't confirmed here. We weren't able to confirm how many antidepressant trials Texas Medicaid currently requires, and managed care plans may differ. Ask the clinic to check your plan's current criteria.

Does Medicare cover Spravato?

Medicare may cover Spravato for its FDA-approved uses. How it's billed, and so what you pay, depends on who supplies the medicine.

• If the clinic buys and supplies the medicine, Medicare Part B is billed with a single visit code that bundles the medicine, the supervised dose and the 2-hour observation together. Your Part B deductible and coinsurance apply.
• If a specialty pharmacy supplies the medicine, the pharmacy bills it to your Part D drug plan, and the clinic bills Part B separately for the visit and monitoring time. Your Part D plan's cost-sharing applies to the medicine.

So two people on Medicare can owe very different amounts, and a Medicare Advantage, Medigap or secondary plan changes the picture further. Ask the clinic which model it uses and what that means under your plan. Medicare patients can't use the manufacturer's savings programs below.

What about TRICARE or VA coverage?

We weren't able to confirm how TRICARE or VA benefits currently handle Spravato, so we won't guess. Ask the clinic to verify your benefits before you schedule, and check with TRICARE or your VA care team about referral or authorization steps. Both manufacturer programs below exclude TRICARE, Department of Defense and VA coverage.

Can the manufacturer's savings programs lower my cost?

Johnson & Johnson, Spravato's manufacturer, runs two separate programs under the name SPRAVATO withMe. Both are for people with commercial (private) insurance only.

SPRAVATO withMe Savings Program (for the medicine). Eligible patients may pay as little as $10 per treatment for Spravato medicine costs. Terms apply:

• You must be 18 or older, have commercial or private insurance, and have out-of-pocket costs for the medicine.
• It isn't available to anyone using Medicare, Medicaid, TRICARE, DoD, VA or any other state or federal healthcare program. Some plans with "accumulator" or "maximizer" designs are excluded too.
• It covers the medicine only. It does not cover the observation visit.
• An annual maximum and quantity limits apply, and you enroll before receiving the medicine. Terms expire each calendar year and may change or end without notice.

SPRAVATO withMe Observation Rebate Program (this covers the monitoring time). Through this one, you can get a rebate on your out-of-pocket costs for the observation portion of each treatment, up to a calendar-year maximum. This one's commercial-only too, and residents of Massachusetts, Minnesota or Rhode Island can't use it.

You can reach SPRAVATO withMe at 844-479-4846 (844-4S-WITHME) to ask about eligibility.

What should I gather before a benefits check?

A benefits check goes faster when your history is in one place. Collect:

• Your insurance cards, front and back, including any secondary plan or separate Part D drug card. If you're checking whether MindVibe accepts your plan, start with our insurance information.
• Your medication history: every antidepressant you've tried, the dose, roughly how long you took it, and why it stopped (side effects or not enough improvement). Pharmacy printouts help with fill dates. See our guide to organizing your depression medication history.
• Any prior authorization letters, whether approvals or denials, for Spravato or other depression treatments.
• Recent depression scores, such as a PHQ-9, if a past clinician recorded them.
• Contact details for your current prescriber and any therapist, so records can be requested with your written permission.

Where can I get Spravato with MindVibe in Texas?

MindVibe offers Spravato in Texas at our REMS-certified Houston treatment center. Every certified center is listed on our Spravato treatment page.

Coverage and clinical fit are separate questions: a psychiatric evaluation with our psychiatric clinicians decides whether Spravato is appropriate for you, and neither guarantees the other. If it isn't the right fit, there are other options in depression treatment. When you're ready, start the booking process.

Important safety information

Spravato (esketamine) nasal spray, CIII, is a prescription medicine for adults with treatment-resistant depression. It can be used on its own or paired with an oral antidepressant. Doctors also prescribe it alongside an oral antidepressant to treat depressive symptoms in adults with major depressive disorder who have suicidal thoughts or actions. It isn't approved for use as an anesthetic, and it isn't approved for anyone under 18. Keep in mind that Spravato hasn't been shown to prevent suicide, nor to reduce suicidal thoughts or actions. Do not use it if you have an aneurysm or other blood-vessel disease, an arteriovenous malformation, past brain bleeding, or an allergy to esketamine or ketamine.

Spravato carries a Boxed Warning. It can cause sedation (sleepiness), dissociation (feeling disconnected from yourself, your thoughts or your surroundings) and respiratory depression (slowed breathing). It has a potential for abuse and misuse. Antidepressants may increase suicidal thoughts and behaviors in people 24 and younger, so call your provider right away about new or worsening depression or suicidal thoughts.

Spravato is available only through a restricted program called the SPRAVATO REMS and is given only in certified healthcare settings. A healthcare provider will monitor you for at least 2 hours after every dose, until they decide you're ready to leave. Do not drive or operate machinery until the next day after a restful sleep, so plan for someone to drive you home. Read the full Prescribing Information, including the Boxed Warning, and the Medication Guide.

If you are in crisis: call or text 988 to reach the Suicide & Crisis Lifeline, available 24/7, or call 911 or go to the nearest emergency room if you or someone else is in immediate danger.

Sources

• SPRAVATO Prescribing Information, Janssen / Johnson & Johnson, rev. March 2026: https://www.jnjlabels.com/package-insert/product-monograph/prescribing-information/SPRAVATO-pi.pdf
• SPRAVATO Medication Guide (DailyMed): https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d81a6a79-a74a-44b7-822c-0dfa3036eaed&audience=consumer
• Johnson & Johnson, monotherapy approval press release (Jan. 21, 2025): https://www.jnj.com/media-center/press-releases/spravato-esketamine-approved-in-the-u-s-as-the-first-and-only-monotherapy-for-adults-with-treatment-resistant-depression
• Johnson & Johnson, SPRAVATO Prior Authorization Toolkit (rev. 01/25): https://www.spravatohcp.com/files/Prior_Authorization_Toolkit.pdf
• UnitedHealthcare Commercial/IEX Medical Benefit Drug Policy 2026D0069Q, effective May 1, 2026: https://www.uhcprovider.com/content/dam/provider/docs/public/policies/comm-medical-drug/ketalar-spravato.pdf
• TMHP, Spravato prior authorization criteria notice (Nov. 13, 2020): https://www.tmhp.com/news/2020-11-13-prior-authorization-criteria-esketamine-spravato-be-updated-texas-medicaid
• TMHP, Spravato prior authorization update (Sept. 12, 2025): https://www.tmhp.com/news/2025-09-12-texas-medicaid-prior-authorization-update-esketamine-spravato-effective-october-1
• Johnson & Johnson, SPRAVATO Coding Overview (12/25): https://www.spravatohcp.com/files/spravato_coding_overview_brochure_digital_version.pdf
• CGS Medicare, Esketamine billing (rev. Dec. 2023): https://cgsmedicare.com/partb/pubs/news/2023/05/cope138216.html
• SPRAVATO withMe Savings Program Requirements (October 2025): https://spravato.com/files/spravatowithmeprogramrequirements.pdf
• SPRAVATO withMe Observation Rebate Program Requirements (July 2025): https://spravato.com/files/spravatowithmeprogramrequirementsorp.pdf
• SPRAVATO withMe Cost Support Enrollment Form (09/2025): https://www.spravato.com/files/CostSupportEnrollmentForm.pdf

Frequently asked questions

Will my insurance pay for Spravato in Texas?

It depends on your plan. Commercial plans, Texas Medicaid and Medicare each have a path to paying for Spravato, but almost all require prior authorization first. Plans usually want records of treatment-resistant depression, a baseline depression score and a REMS-certified site. What you owe depends on your deductible, copay or coinsurance and how your plan bills the medicine and the monitoring visit.

Does insurance require me to be on an oral antidepressant before approving Spravato?

Not always. The FDA label allows Spravato for treatment-resistant depression on its own or with an oral antidepressant, and some plans, including UnitedHealthcare's commercial policy and Texas Medicaid, now allow it alone. Other plans may still require an oral antidepressant alongside it. Ask your clinic to check your plan's current criteria, and never stop or change a medication on your own.

How many antidepressants do I need to have tried?

Many plans look for at least two antidepressants that didn't help enough at an adequate dose and duration. UnitedHealthcare's commercial policy effective May 1, 2026, for example, asks for at least two, each taken for at least 8 weeks. Some plans ask for more. For Texas Medicaid, the exact number wasn't confirmed, and managed care plans may differ, so have the clinic check your plan.

Can I use the $10 savings program if I have Medicare or Texas Medicaid?

No. The SPRAVATO withMe Savings Program is for people with commercial or private insurance only. It excludes anyone using Medicare, Medicaid, TRICARE, DoD, VA or any other state or federal healthcare program. The separate Observation Rebate Program has the same commercial-only rule. If you have government coverage, your plan's own cost-sharing rules decide what you pay.

Does the savings program cover the 2-hour monitoring visit?

No. The SPRAVATO withMe Savings Program covers the medicine only. Observation costs fall under a separate Observation Rebate Program, which is also limited to commercially insured patients, has a calendar-year maximum and isn't available to residents of Massachusetts, Minnesota or Rhode Island. You can call SPRAVATO withMe at 844-479-4846 to ask about eligibility for either program.

What if my prior authorization for Spravato is denied?

A denial isn't always final: check the letter for the reason, keep a copy, and ask the clinic whether the request can be resubmitted with more records or appealed.

This article is for educational purposes only and is not medical, billing or insurance advice, a diagnosis, or a treatment recommendation. Plan policies and manufacturer programs change often; confirm coverage with your insurer. Talk with your own clinicians before making any change to your care. If you are in crisis, call or text 988.